Xun, M., Wang, J., Xie, Q., Peng, B., Li, Z., Guo, Z., . . . He, S. (2023). FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma. Elsevier.
Chicago Style (17th ed.) CitationXun, Min, et al. FBXL19 Promotes Malignant Behaviours by Activating MAPK Signalling and Negatively Correlates with Prognosis in Hepatocellular Carcinoma. Elsevier, 2023.
MLA (9th ed.) CitationXun, Min, et al. FBXL19 Promotes Malignant Behaviours by Activating MAPK Signalling and Negatively Correlates with Prognosis in Hepatocellular Carcinoma. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.